You searched for...

in Search Complimentary Medicines (CAMS) Registaration, Medicines Control , SAHPRA/MCC Circular  (clear all)


Found 34 results

Showing 1 to 30

CAMs Specified Substances 7.06 v2, Jun 2018

COMPLEMENTARY MEDICINES GUIDANCE ON SPECIFIED SUBSTANCES

Related Tags (New Search): Complementary medicines

See Detailed Results

ROADMAP FOR REGISTRATION OF COMPLEMENTARY MEDICINES

This document has been prepared to serve as a recommendation to applicants wishing to register complementary medicines for which claims of safety, quality and efficacy are being made and which have been called up for registration. It represents the Medicines…

Related Tags (New Search): Complementary medicines,   Health supplements

See Detailed Results

Scheduling of Medicines (MCC: 2.36, Jun 2014)

This guideline provides applicant information for applicants on the scheduling of medicine submitted for registration. It includes a description of each of the 8 schedules and general guidelines for categorisation and for application scheduling of medicines.

Related Tags (New Search): Schedules

See Detailed Results

Veterinary Antimastitis Medicines (MCC: 3.13, Nov 2013)

This guideline provides information on the registration of veterinary anti-mastitis medicines. Circular 3.13

Related Tags (New Search): Veterinary medicine

See Detailed Results

Substitution of Medicines (MCC: 2.10, Apr 2010)

This guideline replaces the guideline on generic substitution published in 2003. It effectively cancels the list of not substitutable medicines. The only medicines declared to be not substitutable following this guideline of Biosimilars.

Related Tags (New Search): Biological medicines

See Detailed Results

Alcohol Content of Medicines (MCC: 2.03, Dec 2003)

Alcohol content of medicines intended for oral administration.

See Detailed Results

Wholesalers to Export Medicines (MCC: 4.10, Feb 2015)

Guidelines for the application for a license for Wholesalers wishing to export medicinal products. Circular 4.10

Related Tags (New Search): Exporters,   Distributor,   Wholesaler

See Detailed Results

Proprietary Names for Medicines (MCC: 2.15, Nov 2014)

The acceptability of proposed proprietary names of products submitted for registration as medicines.

Related Tags (New Search): Naming

See Detailed Results

Labeling of Medicines Containing Sugars (MCC: 2.35, Dec 2015)

The document provides guidance to applicants on how to label medicines containing “sugar” so as to alert prescribers and users who need to take cognisance of the presence of any sugar in the medicine and to take the necessary steps…

Related Tags (New Search): Application,   Labeling

See Detailed Results

Package Inserts for Human Medicines (MCC: 2.16, Feb 2015)

The document provides recommendations to applicants regarding package inserts. For more information, go to www.mccza.com Please note that this is a third-party website. Juta has no control over the nature, content or availability of third-party websites, and shall not be liable,…

Related Tags (New Search): Pack insert,   Application

See Detailed Results

Roadmap for Registration of Complementary Medicines (MCC: 7.02, Dec 2013)

This guideline gives information to applicants wishing to register complimentary medicines for which claims of safety, quality and efficacy are being made and which have been called up for registration. It provides for implementation of Government Notice R870 of 15…

Related Tags (New Search): Complementary medicines,   Application

See Detailed Results

Complementary Medicines – Health Supplements Safety and Efficacy (MCC: 7.04, Jun 2016)

This guideline provides information required for the application for registration of health supplements. The guideline provides details on compliance with GMP, GLP and good agricultural and collection practices. It also provides the format for the presentation of administrative information, common…

Related Tags (New Search): Health supplements,   Vitamins & Minerals,   Safety and performance,   Application,   Efficacy,   CTD

See Detailed Results

Guidelines for Recall/Withdrawal of Medicines (MCC: 5.07, Dec 2008)

This document provides information on the record of medicines and covers notification for initiations of a recall, information required for assessment of a recall, classification, communications and procedures.

Related Tags (New Search): Recalls

See Detailed Results

Bioavailability and Bioequivalence of Veterinary Medicines (MCC: 3.03, Jan 2004)

Bioavailability and Bioequivalence of Veterinary Medicines. Secular 3.03

Related Tags (New Search): Veterinary medicine

See Detailed Results

Complementary Medicines – Registration Application ZA-CTD - Quality (MCC: 7.05, Jun 2016)

This guideline provides information required for the submission of an application for registration of a complimentary medicine. The guideline gives details on the administrative information, common technical document summaries and quality information required for a registration application.

Related Tags (New Search): Complementary medicines,   Health supplements,   Application

See Detailed Results

General Information: Complementary and Alternative Medicines Submissions (MCC: 9.37, Jan 2011)

General Information: Complementary and Alternative Medicines Submissions in response to Government Notice of 22nd February 2002

Related Tags (New Search): Complementary medicines

See Detailed Results

Efficacy of and GCP for Veterinary Medicines (MCC: 3.04, Jun 2003)

This documents provides guidelines on the conduct of clinical trials on veterinary medicines including requirements for safety, quality and efficacy. Circular 3.04

Related Tags (New Search): Veterinary medicine

See Detailed Results

Section 21 Applications for Unregistered Veterinary Medicines (MCC: 3.11, Jan 2004)

This guideline provides information on the application for use of unregistered veterinary medicines. Circular 3.11

Related Tags (New Search): Exemptions,   Veterinary medicine

See Detailed Results

Package Inserts for Human Medicines Standard texts (MCC: 2.20, Mar 2016)

The document indicates standardised texts or wording that must be included into package inserts for certain medicines. For more information, go to www.mccza.com Please note that this is a third-party website. Juta has no control over the nature, content or availability…

Related Tags (New Search): Pack insert,   Application

See Detailed Results

Guidelines for Parallel Importation of Medicines in South Africa (MCC: 5.02, Jun 2003)

Guidelines for Parallel Importation of Medicines in South Africa

Related Tags (New Search): Exporters,   Importers

See Detailed Results

Guideline on Preclinical Safety Studies for Veterinary Medicines (MCC: 3.05, Jan 2004)

Guideline on Preclinical Safety Studies for Veterinary Medicines. Secular 3.05

Related Tags (New Search): Safety and performance,   GCP,   Veterinary medicine

See Detailed Results

Guidelines for the Importation and Exportation of Medicines (MCC: 5.01, Jun 2011)

Guidelines for the Importation and Exportation of Medicines

Related Tags (New Search): Exporters,   Importers

See Detailed Results

Guidelines for the Destruction of Schedule 6 Medicines and Substances (MCC: 5.06, May 2003)

This document provides recommendations to applicants wishing to destroy any schedule 6 medicines and or substances.

Related Tags (New Search): Disposal,   S6

See Detailed Results

SA GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINES (v6, MCC: 4.01, Dec 2017)

Guide to Good Manufacturing Practice for Medicines in South Africa, Circular 4.01

Related Tags (New Search): GMP,   GWP,   PICS

See Detailed Results

Guide to Good Manufacturing Practice for Medicines in South Africa (MCC: 4.01, Nov 2010)

Guide to Good Manufacturing Practice for Medicines in South Africa. Circular 4.01

Related Tags (New Search): GMP

See Detailed Results

Guidelines for the Destruction of Schedule 5 Medicines and Substances (MCC: 5.05, May 2003)

This document provides recommendations to applicants wishing to destroy schedule 5 medicines and or substances

Related Tags (New Search): Disposal,   S5

See Detailed Results

Guidelines for Recall/Withdrawal of Medicines, Medical Devices and IVDs (MCC: 5.07, Nov 2015)

This is a draft guideline incorporating medical devices. Not yet finalised

Related Tags (New Search): GMP,   QMS,   IVDs,   Non-compliance,   Recall,   Recalls,   Safety,   Adverse Drug Reaction,   SRPINS,   Adverse Drug Event

See Detailed Results

Guideline for the Direct Transmission of Fees Payable to the Registrar Of Medicines (MCC: 17.02, Jul 2009)

This guideline has been prepared to serve as a guideline to enable the direct payment of fees into the bank account of the Medicines Control Council and must be read together with the Guideline on Fees Payable to The Registrar…

Related Tags (New Search): Guidelines

See Detailed Results

(Showing 1 to 30 of 34 results)